Marex director granted 2,070 restricted shares

Myers Linda Kristine reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Myers Linda Kristine reported acquisition or exercise transactions in this Form 4 filing.

Marex Group plc director Linda Kristine Myers reported receiving an equity grant of 2,070 restricted share awards of Ordinary Shares on June 9, 2026 at no cash cost per share. Each award is a contingent right to one ordinary share upon vesting and settlement. Following this grant, she directly holds 23,214 Ordinary Shares, reflecting routine share-based compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 2,070 shares

Grant/Award 1 txn

Insider Myers Linda Kristine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,070	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 23,214 shares (Direct)

Footnotes (1)

1. F1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Key Figures

Restricted share awards granted: 2,070 shares Grant price: $0.00 per share Shares held after transaction: 23,214 shares +1 more

4 metrics

Restricted share awards granted 2,070 shares Grant of Ordinary Shares on June 9, 2026

Grant price $0.00 per share Equity compensation award, not an open-market purchase

Shares held after transaction 23,214 shares Total direct Ordinary Shares following the award

Transaction type Grant/award acquisition (Code A) Non-derivative acquisition of Ordinary Shares

Key Terms

restricted share awards, contingent right, Ordinary Shares, Grant, award, or other acquisition

4 terms

restricted share awards financial

"includes 2,070 shares underlying restricted share awards granted to the Reporting Person."

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

contingent right financial

"Each award represents a contingent right to receive one (1) ordinary share"

Ordinary Shares financial

"The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Marex Group (MRX) director Linda Kristine Myers report in this Form 4?

Linda Kristine Myers reported receiving a grant of 2,070 restricted share awards in Marex Group plc Ordinary Shares. These equity awards form part of her compensation and increase her direct holdings to 23,214 Ordinary Shares after the transaction.

Was the Marex Group (MRX) director’s 2,070-share transaction an open-market purchase?

No, the 2,070-share transaction was a grant of restricted share awards at a price of $0.00 per share. It represents share-based compensation, not an open-market buy, and each award converts into one Ordinary Share upon vesting.

How many Marex Group (MRX) shares does Linda Kristine Myers hold after this award?

After receiving 2,070 restricted share awards, Linda Kristine Myers directly holds 23,214 Marex Group plc Ordinary Shares. This total includes the shares underlying the newly granted awards, which will deliver one share each if and when they vest.

What are the terms of the 2,070 Marex Group (MRX) restricted share awards?

Each of the 2,070 restricted share awards represents a contingent right to receive one Marex Group plc Ordinary Share. The shares will be delivered only upon vesting and settlement of the applicable award, according to the company’s equity plan terms.

Does the Marex Group (MRX) Form 4 show any share sales by the director?

No, the filing only shows an acquisition via a grant of 2,070 restricted share awards, coded as a grant or award. There are no reported sales, dispositions, or derivative exercises for Linda Kristine Myers in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Myers Linda Kristine

(Last) (First) (Middle)

C/O MAREX GROUP PLC, 155 BISHOPSGATE

(Street)

LONDON UNITED KINGDOM EC2M 3TQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marex Group plc [ MRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/09/2026		A		2,070	A	$0	23,214(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

	/s/ Scott Linsley as Attorney-in-Fact, for Linda K. Myers	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)